DelPHI: A Novel Program to Accelerate Access to Precision Oncology in the Community Oncology Setting

Authors: Anthony Martin Magliocco, Roy Khalife, Catherine Wilson, Tara M Love, Rama Balaraman
Journal: Journal of Clinical Oncology | Volume 41
Publisher: American Society of Clinical Oncology

---

Background:

It has been well recognized that the rapid advances in precision oncology have not fully been translated into improved access for community cancer programs in the USA, where as much as 95% of oncological assessment and treatment occurs. To address this growing gap, Protean BioDiagnostics and Roche Information Solutions have created a novel project to improve the Delivery of Precision Health Information (DelPHI) to community-based oncology programs using an innovative precision oncology testing system (MAPS™) integrated with a digital decision support and telemedicine framework (navify). The project seeks to bridge the clinical and administrative gaps to help bring precision oncology to the community.

https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e18713